CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 68 enrolled
Drug / intervention
Lipitor 20Mg Tablet +2 moredrug
Likely dose
Lipitor 20Mg Tabletfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03351998
NCT03351998Phase 4Completed
CompareCT.gov

Impact of Statin Therapy on Muscle Mitochondrial Function and Aerobic Capacity

University of Kansas Medical Center·interventional·Posted Nov 24, 2017·Updated Dec 18, 2024

In Brief

A Phase 4 clinical trial evaluating Lipitor 20Mg Tablet, Lipitor 80Mg Tablet, and 1 other intervention for Mitochondrial Diseases. Completed, enrolled 68 participants across 2 sites.

Detailed Summary

The purpose of this study is to test how different doses of a statin, Lipitor, affect muscle health and function, and cardiovascular fitness.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMitochondrial Diseases
CountriesUnited States
CollaboratorsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedNov 24, 2017
Enrollment StartFeb 22, 2018
Primary CompletionJul 7, 2023
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 8.6 years ago

Interventions

Lipitor 20Mg Tabletdrug

20 mg/day pills.

Lipitor 80Mg Tabletdrug

80 mg/day pills.

Placebo Oral Tabletdrug

Matching placebo pill.